Compare drug alternatives

Cosentyx® Alternatives

Cosentyx®(secukinumab)
Skyrizi®(risankizumab)
Prescription Only
Cosentyx is a monoclonal antibody treatment option for several conditions, including plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and others. Following the...
Prescription Only
Skyrizi, an interleukin inhibitor, is prescribed to alleviate inflammation associated with plaque psoriasis, psoriatic arthritis, or Crohn's disease in adults. The recommended...
Dosage & Administration
Administration
Subcutaneous Injection. Learn more.
Subcutaneous Injection. Learn more.
Dosing
* With a loading dosage: 150 mg at Weeks 0, 1, 2, 3, and 4 and every 4 weeks thereafter. * Without a loading dosage: 150 mg every 4 weeks.. Learn more.
150 mg at Week 0, Week 4, and every 12 weeks thereafter.. Learn more.
Latin Shorthand
W/ Loading Dose: 150mg Wks 0,1,2,3,4, then q4wks. W/o Loading Dose: 150mg q4wks.. Learn more.
150 mg Week 0, 4 then q12w. Learn more.
Adverse Reactions
Most common adverse reactions (> 1%) are nasopharyngitis, diarrhea, and upper respiratory tract infection. . Learn more.
Most common adverse reactions are: • Plaque Psoriasis and Psoriatic Arthritis (≥ 1%): upper respiratory infections, headache, fatigue, injection site reactions, and tinea infections. • Crohn’s Disease (>3%): o Induction: upper respiratory infections, headache, and arthralgia. o Maintenance: arthralgia, abdominal pain, injection site reactions, anemia, pyrexia, back pain, arthropathy, and urinary tract infection. . Learn more.
Financial Assistance
Out-Of-Pocket Costs With Copay Card
Annual Cap
$6,000. Learn more.
Assistance Expiration
Generics
No lower-cost generic available
No lower-cost generic available